• Latest Posts

AMR research gets £39m shot from UK government

Industry responds to UK science strategy launch

Sania Therapeutics launches to advance neural circuit dysfunction medicines

LabGenius looks to create molecules with huge increase in tumor killing ability

Achilles Therapeutics’ new platform identifies most potent T-cell antigens


5 highlights at first Genomics and Precision Medicine Expo

Six synthetic biology companies that have made a mark

aVaxziPen’s needle-free vaccine yields positive data across multiple diseases

LifeArc launches £40M funding call to create Translational Rare Disease Centres 

LIfT BioSciences hails breakthrough data for treating solid tumors

SpyBiotech receives more than $4 million to develop vaccine platform